Significantly improved HIV inhibitor efficacy prediction employing proteochemometric models generated from antivirogram data.
Infection with HIV cannot currently be cured; however it can be controlled by combination treatment with multiple anti-retroviral drugs. Given different viral genotypes for virtually each individual patient, the question now arises which drug combination to use to achieve effective treatment. With t...
Main Authors: | Gerard J P van Westen, Alwin Hendriks, Jörg K Wegner, Adriaan P Ijzerman, Herman W T van Vlijmen, Andreas Bender |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS Computational Biology |
Online Access: | http://europepmc.org/articles/PMC3578754?pdf=render |
Similar Items
-
Which compound to select in lead optimization? Prospectively validated proteochemometric models guide preclinical development.
by: Gerard J P van Westen, et al.
Published: (2011-01-01) -
Identification of novel small molecule inhibitors for solute carrier SGLT1 using proteochemometric modeling
by: Lindsey Burggraaff, et al.
Published: (2019-02-01) -
Predicting the binding type of compounds on the 4 adenosine receptors using proteochemometric models
by: van den Hoven Olaf, et al.
Published: (2010-05-01) -
Molecular bioactivity extrapolation to novel targets by support vector machines
by: Van Westen Gerard JP, et al.
Published: (2010-05-01) -
Quantitative prediction of selectivity between the A1 and A2A adenosine receptors
by: Lindsey Burggraaff, et al.
Published: (2020-05-01)